6/3
04:38 pm
cdna
CareDx Announces Repurchase of 5% of Outstanding Shares [Yahoo! Finance]
High
Report
CareDx Announces Repurchase of 5% of Outstanding Shares [Yahoo! Finance]
6/3
04:30 pm
cdna
CareDx Announces Repurchase of 5% of Outstanding Shares
High
Report
CareDx Announces Repurchase of 5% of Outstanding Shares
5/22
09:27 am
cdna
Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders
Low
Report
Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders
5/21
08:48 pm
cdna
Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders
Low
Report
Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders
5/13
04:01 pm
cdna
CareDx to Participate in Upcoming Investor Conferences
Low
Report
CareDx to Participate in Upcoming Investor Conferences
5/5
11:08 pm
cdna
CareDx, Inc (NASDAQ: CDNA) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Medium
Report
CareDx, Inc (NASDAQ: CDNA) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
5/5
09:26 am
cdna
CareDx, Inc (NASDAQ: CDNA) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $40.00 price target on the stock.
Low
Report
CareDx, Inc (NASDAQ: CDNA) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $40.00 price target on the stock.
5/5
08:11 am
cdna
CareDx, Inc (NASDAQ: CDNA) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock.
Low
Report
CareDx, Inc (NASDAQ: CDNA) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock.
4/30
04:20 pm
cdna
CareDx Reports First Quarter 2025 Results [Yahoo! Finance]
High
Report
CareDx Reports First Quarter 2025 Results [Yahoo! Finance]
4/30
04:05 pm
cdna
CareDx Reports First Quarter 2025 Results
High
Report
CareDx Reports First Quarter 2025 Results
4/29
07:21 am
cdna
CareDx Announces New Data on AlloSure Lung Presented at 2025 International Society for Heart and Lung Transplantation Meeting [Yahoo! Finance]
Low
Report
CareDx Announces New Data on AlloSure Lung Presented at 2025 International Society for Heart and Lung Transplantation Meeting [Yahoo! Finance]
4/29
07:05 am
cdna
CareDx Announces New Data on AlloSure Lung Presented at 2025 International Society for Heart and Lung Transplantation Meeting
Low
Report
CareDx Announces New Data on AlloSure Lung Presented at 2025 International Society for Heart and Lung Transplantation Meeting
4/24
07:22 am
cdna
CareDx Announces Presentation of 60 Abstracts Including 19 Oral Presentations at the 2025 International Society for Heart and Lung Transplantation Meeting [Yahoo! Finance]
Low
Report
CareDx Announces Presentation of 60 Abstracts Including 19 Oral Presentations at the 2025 International Society for Heart and Lung Transplantation Meeting [Yahoo! Finance]
4/24
07:05 am
cdna
CareDx Announces Presentation of 60 Abstracts Including 19 Oral Presentations at the 2025 International Society for Heart and Lung Transplantation Meeting
Medium
Report
CareDx Announces Presentation of 60 Abstracts Including 19 Oral Presentations at the 2025 International Society for Heart and Lung Transplantation Meeting
4/21
04:01 pm
cdna
CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
4/17
02:33 pm
cdna
CareDx, Inc (NASDAQ: CDNA) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $34.00 to $26.00. They now have a "buy" rating on the stock.
Low
Report
CareDx, Inc (NASDAQ: CDNA) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $34.00 to $26.00. They now have a "buy" rating on the stock.
4/8
07:18 am
cdna
CareDx to Report First Quarter 2025 Financial Results [Yahoo! Finance]
Medium
Report
CareDx to Report First Quarter 2025 Financial Results [Yahoo! Finance]
4/8
07:05 am
cdna
CareDx to Report First Quarter 2025 Financial Results
Medium
Report
CareDx to Report First Quarter 2025 Financial Results
3/28
06:07 pm
cdna
CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA
Low
Report
CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA